1. Home
  2. VLRS vs STOK Comparison

VLRS vs STOK Comparison

Compare VLRS & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLRS
  • STOK
  • Stock Information
  • Founded
  • VLRS 2005
  • STOK 2014
  • Country
  • VLRS Mexico
  • STOK United States
  • Employees
  • VLRS N/A
  • STOK N/A
  • Industry
  • VLRS Air Freight/Delivery Services
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • VLRS Consumer Discretionary
  • STOK Health Care
  • Exchange
  • VLRS Nasdaq
  • STOK Nasdaq
  • Market Cap
  • VLRS 546.3M
  • STOK 638.8M
  • IPO Year
  • VLRS N/A
  • STOK 2019
  • Fundamental
  • Price
  • VLRS $4.53
  • STOK $13.39
  • Analyst Decision
  • VLRS Strong Buy
  • STOK Strong Buy
  • Analyst Count
  • VLRS 6
  • STOK 5
  • Target Price
  • VLRS $8.35
  • STOK $27.75
  • AVG Volume (30 Days)
  • VLRS 746.7K
  • STOK 605.2K
  • Earning Date
  • VLRS 07-22-2025
  • STOK 08-06-2025
  • Dividend Yield
  • VLRS N/A
  • STOK N/A
  • EPS Growth
  • VLRS N/A
  • STOK N/A
  • EPS
  • VLRS 0.04
  • STOK 0.88
  • Revenue
  • VLRS $3,052,207,000.00
  • STOK $190,908,000.00
  • Revenue This Year
  • VLRS $2.04
  • STOK $378.84
  • Revenue Next Year
  • VLRS $12.38
  • STOK N/A
  • P/E Ratio
  • VLRS $13.04
  • STOK $15.11
  • Revenue Growth
  • VLRS N/A
  • STOK 2333.81
  • 52 Week Low
  • VLRS $3.49
  • STOK $5.35
  • 52 Week High
  • VLRS $9.00
  • STOK $16.15
  • Technical
  • Relative Strength Index (RSI)
  • VLRS 49.52
  • STOK 72.60
  • Support Level
  • VLRS $4.59
  • STOK $11.66
  • Resistance Level
  • VLRS $4.95
  • STOK $12.11
  • Average True Range (ATR)
  • VLRS 0.21
  • STOK 0.47
  • MACD
  • VLRS -0.01
  • STOK 0.03
  • Stochastic Oscillator
  • VLRS 44.83
  • STOK 85.78

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: